Corrigendum to “Platelet-Rich Plasma Improves the Wound Healing Potential of Mesenchymal Stem Cells through Paracrine and Metabolism Alterations”

Figure 2

PRP treatment stimulates the proangiogenic properties of engrafted human MSC (hMADS cells) into mouse wounds. (a) Left panel: representative CD31 immunostaining of mouse wounds (red signal) at day 3 following treatment with saline solution, PRP, hMADS cells, or hMADS cells in combination with PRP, respectively. Nuclei were counterstained with Hoechst 33342 (blue signal). Scale bar, 50 μm. Right panels: quantification of CD31-positive cells in mouse wounds at day 3 and day 7 following treatment with saline solution, PRP, hMADS cells, or hMADS cells in combination with PRP, respectively. (b) Relative human VEGF and human SDF-1 transcriptional expression in mouse wounds corresponding to the expression of hMADS cells engrafted in combination with PRP by reference to the expression in hMADS cells engrafted alone, at day 1, day 3, and day 7 postinjury. Results represent the mean ± SD obtained from at least n = 5 mice per group. , , , .

(a)

(b)